Pharmaceutical Care in People who have had Acute Coronary Episodes (TOMCOR Study)

Authors

  • Flor Álvarez de Toledo
  • Pedro Arcos González
  • Teresa Eyaralar Riera
  • Francisco Abal Ferrer
  • Ana Dago Martínez
  • Laura Cabiedes Miragaya
  • Ignacio Sánchez Posada
  • Gabriela Alvarez Sánchez

Abstract

Methods: A randomized prospective controlled-intervention study was conducted in 83 community pharmacies in the provinces of Asturias, Barcelona, Madrid and Biscay in a one-year monitoring of the drug-use of 735 patients at the start of the study (330 intervention patients and 405 control) and 600 at the end. Results: Differences were fund in favor of the intervention group in: a) the use of health care services as a morbidity indicator such as frequency of hospital emergency room visits 1.27 I (CI95 %; 1.10 - 1.44) and 1.63C (CI95 %; 1.36 1.90) or average length-of-stay in Intensive Care Units 2.46 I (CI95 %; 1.56 3.36) and 5.87 C (CI95 %; 3.57 8.17), both due to coronary causes; b) health-related quality of life score (physical functioning dimension difference of 4.7 (p < 0.05); c) average patient knowledge of coronary heart disease risk factors having improved by 10 % (p < 0002 0.007 depending on dimension); d) patient knowledge of the name and identification of their drugs having improved by 10 % (p < 0.001) along with their subjective perception of the antiagregans drugs relative importance having improved by 12 % (p < 0.009) and effects of beta-blockers having improved by 25 % (p < 0.02); e) average satisfaction with pharmaceutical care service and perception of pharmacists professional competence having improved by 2 % (p < 0.000 to 0.05 depending on dimension). Conclusions: A decrease in emergency health care demand due to coronary causes, a fewer number of patient hospitalizations and a shorter length-of-stay in Coronary Intensive Care Units due to hospitalization regarding coronary patients on pharmaceutical care would suggest that patients who suffered an acute coronary heart episode made a better use of drugs and would tend to be less ill. Furthermore, coronary patients who received pharmaceutical care services showed a better knowledge of the reasons for their pharmacotherapy and therefore took better advantage of health care resources and improved their health condition.

Published

2008-04-14

Issue

Section

ORIGINALS